NBCD A/S: Financial statements 2022
CVR: 30582462
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
NBCD A/S (CVR 30582462) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 94,669,194 and a net result of DKK 45,856,530 compared with DKK 35,649,029 the year before. That is an increase of 56.6% compared with the year before. Equity in the 2022 report amounted to DKK 123,494,859. The solvency ratio was 52.2%. The company had 23 employees in the financial year.
- Gross Profit
- DKK 94,669,194
- Profit/Loss
- DKK 45,856,530
- Equity
- DKK 123,494,859
- Total Assets
- DKK 236,619,470
- Employees
- 23
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 94.7 mio. | 45.9 mio. | 123.5 mio. | 23 |
| 2021 | - | 60.4 mio. | 35.6 mio. | 107.6 mio. | 20 |
| 2020 | - | 59.7 mio. | 40.5 mio. | 72 mio. | 23 |
| 2019 | - | 48.9 mio. | 33.7 mio. | 36.5 mio. | 20 |
| 2018 | - | 26.7 mio. | 16.3 mio. | 17.8 mio. | 25 |
Official annual report
Keep an eye on NBCD A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
NBCD A/S has published its annual report for 2021. Gross profit came to DKK 60,448,632, and the net result was DKK 35,649,029.
About NBCD A/S
NBCD A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S and NORDIC BIOSCIENCE PROJECT 2 A/S. The management consists of Jeppe Ragnar Andersen and Mark Høgh Gandrup. The board consists of Pierre Khaitrine (chair), Jeppe Ragnar Andersen and José Ignacio Pfeifer. The company is owned by Sanos Holding A/S. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 31,583,144 and a net result of DKK 9,222,892 compared with DKK 52,621,101 the year before. Equity in the 2025 report amounted to DKK 136,144,994.